MMJ announces MediPharm Labs has been added to HMMJ

Company News

by Rachael Jones

Cannabis investment company MMJ Group Holdings (ASX:MMJ) is pleased to announce that MediPharm Labs has been added  to the Horizons Marijuana Life Sciences Index ETF.

MMJ owns approximately 4.4 million shares for a 4.5 per cent shareholding and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, cultivation, equipment and retail.

Shares in MMJ Group Holdings (ASX:MMJ) are trading 2.17 per cent lower at $0.23.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.